Healthy Extracts Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYEX research report →
Price Chart
About the company
Healthy Extracts Inc. , through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy.
- CEO
- Donald Swanson
- IPO
- 2015
- Employees
- 22
- HQ
- Henderson, NV, US
Get TickerSpark's AI analysis on HYEX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.90M
- P/E
- -8.50
- Fwd P/E
- 10.38
- PEG
- 0.04
- P/S
- 3.16
- P/B
- 0.98
- EV/EBITDA
- -59.17
- Div Yield
- 0.00%
- Gross Margin
- 61.14%
- Op Margin
- -17.60%
- Net Margin
- -13.98%
- ROE
- -3.72%
- ROIC
- -3.51%
Latest fiscal year · YoY change
- Revenue
- $4.51M+44.9%
- Gross Profit
- $2.42M+26.7%
- Op Income
- $-943,850
- Net Income
- $-881,119-4.8%
- EPS
- $-0.09+66.2%
- OCF Growth
- -41.3%
- FCF Growth
- -48.1%
- 52W High
- $3.35
- 52W Low
- $0.81
- 50D MA
- $1.69
- 200D MA
- $1.87
- Beta
- -0.77
- RSI (14)
- 47
- Avg Volume
- 408
No earnings-call transcripts are available for HYEX yet.
- Free Float
- 8.8%
- Shares Outstanding
- 14.74M
- Float Shares
- 1.30M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 19, 25 | Swanson Donald William | buy | 13,075,920 |
| Jul 19, 25 | Swanson Donald William | other | 0 |
| Jun 30, 23 | Croyle William Russell Jr | other | 500,000 |
| Sep 24, 19 | Croyle William Russell Jr | other | 0 |
| Dec 31, 21 | Croyle William Russell Jr | other | 200,000 |
| Apr 13, 20 | Pitts Kevin | other | 610,112 |
| Dec 20, 19 | Pitts Kevin | buy | 200,000 |
| Dec 20, 19 | Pitts Kevin | buy | 2,000,000 |
| Feb 13, 19 | Pitts Kevin | other | 1,620,000 |
| May 31, 22 | Madden Robert Michael | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HYEX coverage
Recent articles, reports, and earnings notes.
No research on HYEX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HYEX report →Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share
accessnewswire.com · Aug 14
Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+
accessnewswire.com · Aug 6
Healthy Extracts Acquires Sommer Ray's Global Health & Beauty Brand, Imaraïs Beauty
accessnewswire.com · May 19
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
accessnewswire.com · May 14
Healthy Extracts' Gummy USA Secures Major U.S. Manufacturing Partnership with Imaraïs Beauty
accessnewswire.com · Apr 16
Healthy Extracts Reports 2025 Net Revenue Up 45% to Record $4.5 Million
accessnewswire.com · Apr 8
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
accessnewswire.com · Apr 2
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
globenewswire.com · Feb 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.